Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL/osteoprotegerin (OPG) ratio and OPG gene polymorphisms

被引:3
作者
Eid, Riham [1 ]
Abdelsalam, Maha [2 ]
Fathy, Aya Ahmed [3 ]
Abolenein, Hadil M. M. [4 ]
Elmarghany, Eman Bakr [5 ]
El-Hanafy, Aya Ahmed [6 ]
Hamdy, Nashwa [1 ]
Abd-Elmagid, Dina Salama [7 ]
Niazy, Nermeen A. A. [3 ]
Abd-El Ghaffar, Dina M. M. [5 ]
机构
[1] Mansoura Univ, Childrens Hosp, Fac Med, Paediat Nephrol Unit, Mansoura 35561, Egypt
[2] Mansoura Univ, Fac Med, Ctr Res & Regenerat Med, Clin Pathol Dept, Cairo, Egypt
[3] Mansoura Univ, Fac Med, Publ Hlth & Community Dept, Mansoura, Egypt
[4] Mansoura Univ, Childrens Hosp, Fac Med, Paediat Endocrinol & Diabet Unit, Mansoura, Egypt
[5] Mansoura Univ, Fac Med, Rheumatol Rehabil & Phys Med Dept, Mansoura, Egypt
[6] Mansoura Univ, Fac Med, Med Biochem Dept, Mansoura, Egypt
[7] Mansoura Univ, Childrens Hosp, Fac Med, Paediat Neurol Unit, Mansoura, Egypt
关键词
sRANKL; Osteoprotegerin; OPG gene; Juvenile idiopathic arthritis; Bone mineral density; KAPPA-B LIGAND; RECEPTOR ACTIVATOR; ETANERCEPT TREATMENT; SELECT CATEGORIES; OSTEOPROTEGERIN; RANKL; MASS; DISEASE; VALIDATION; INFLIXIMAB;
D O I
10.1186/s12969-023-00843-6
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
BackgroundChildren with juvenile idiopathic arthritis (JIA) are at higher risk of decreased bone mineral density (BMD) compared with healthy children due to genetic, disease and medication-related causes. This study aims to investigate the possible effects of osteoprotegerin (OPG) gene polymorphisms and serum levels of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B-ligand (RANKL) and RANKL/OPG ratio on BMD in children with JIA.MethodsOPG gene rs2073617, rs3134069, serum RANKL, OPG and RANKL/OPG ratio were evaluated in 60 JIA children and 100 matched healthy controls. BMD was evaluated by lumbar dual energy X-ray absorptiometry (DEXA) according to which patients were classified in 2 groups (DEXA z-score above and below - 2). Composite disease activity was measured using the Juvenile Arthritis Disease Activity Score (JADAS) 27-joints. Articular damage was scored using the juvenile arthritis damage index (JADI).ResultsPatients aged 12.05 +/- 3.2 years, included 38 females and 31% had BMD z-score below-2. Systemic-onset JIA was the most frequent phenotype (38%). Genotypes and alleles frequencies of the 2 studied polymorphisms did not differ between patients and controls (p > 0.05 for all) while serum RANKL and RANKL/OPG ratio were significantly higher in patients compared to controls (p = < 0.001 and 0.03 respectively). Patients with BMD < -2 had significantly greater frequencies of rs2073617 TT genotype and T allele (p < 0.001), higher serum RANKL, RANKL/OPG ratio (p = 0.01, 0.002), female predominance (p = 0.02), higher articular and extra-articular damage index (p = 0.008,0.009) and more frequent steroid usage (p = 0.02) compared to patients with BMD z-score >-2. Multivariate analysis showed rs2073617 TT genotype, RANKL/OPG ratio, long disease duration (above 36 months) and use of steroid to be associated with decreased BMD (p = 0.03,0.04,0.01,0.01 respectively) in JIA children.ConclusionsEgyptian children with JIA have decreased BMD. rs2073617 TT genotype and T allele, RANKL/OPG ratio are possible determinants of reduced BMD in JIA. Our results underline the importance of frequent monitoring of BMD in JIA children and trying to control disease activity to preserve long term bone health.
引用
收藏
页数:12
相关论文
共 62 条
[21]   Effect of body composition on bone mineral density in Moroccan patients with juvenile idiopathic arthritis [J].
El Badri, Dalal ;
Rostom, Samira ;
Bouaddi, Ilham ;
Hassani, Asmae ;
Chkirate, Bouchra ;
Amine, Bouchra ;
Hajjaj-Hassouni, Najia .
PAN AFRICAN MEDICAL JOURNAL, 2014, 17 :115
[22]   Low turnover bone disease in Egyptian children with acute leukemia [J].
El-Ziny, MA ;
Al-Tonbary, YA ;
Salama, OS ;
Bakr, AA ;
Al-Marsafawy, H ;
Elsharkawy, AA .
HEMATOLOGY, 2005, 10 (04) :327-333
[23]   Low bone mass in children with malignant lymphoma [J].
El-Ziny, Magdy A. ;
Al-Tonbary, Youssef A. ;
Salama, Osama S. ;
Bakr, Ashraf ;
Al-Marsafawy, Hala ;
Elsharkawy, Ashraf A. .
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2007, 24 (5-8) :577-585
[24]   Low bone mineral density in juvenile idiopathic arthritis: Prevalence and related factors [J].
Galindo Zavala, Rocio ;
Nunez Cuadros, Esmeralda ;
Martin Pedraz, Laura ;
Diaz-Cordoves Rego, Gisela ;
Sierra Salinas, Carlos ;
Urda Cardona, Antonio .
ANALES DE PEDIATRIA, 2017, 87 (04) :218-225
[25]   The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction [J].
Geusens, P. P. ;
Landewe, R. B. M. ;
Garnero, P. ;
Chen, D. ;
Dunstan, C. R. ;
Lems, W. F. ;
Stinissen, P. ;
van der Heijde, D. M. F. M. ;
van der Linden, S. ;
Boers, M. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (06) :1772-1777
[26]   Osteoprotegerin Polymorphisms in a Mexican Population with Rheumatoid Arthritis and Generalized Osteoporosis: A Preliminary Report [J].
Guadalupe Zavala-Cerna, Maria ;
Cristina Moran-Moguel, Maria ;
Alejandro Cornejo-Toledo, Jesus ;
Guadalupe Gonzalez-Montoya, Norma ;
Sanchez-Corona, Jose ;
Salazar-Paramo, Mario ;
Hernan Nava-Zavala, Arnulfo ;
Anita Aguilar-Chavez, Erika ;
Fabiola Alcaraz-Lopez, Miriam ;
Guadalupe Gonzalez-Sanchez, Alicia ;
Gonzalez-Lopez, Laura ;
Ivan Gamez-Nava, Jorge .
JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
[27]  
Hofbauer LC, 2001, ARTHRITIS RHEUM-US, V44, P253, DOI 10.1002/1529-0131(200102)44:2<253::AID-ANR41>3.3.CO
[28]  
2-J
[29]   Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord [J].
Honore, P ;
Luger, NM ;
Sabino, MAC ;
Schwei, MJ ;
Rogers, SD ;
Mach, DB ;
O'Keefe, PF ;
Ramnaraine, ML ;
Clohisy, DR ;
Mantyh, PW .
NATURE MEDICINE, 2000, 6 (05) :521-528
[30]   The pattern of juvenile idiopathic arthritis; a retrospective Egyptian study [J].
Hussein, Zeinab M. ;
Wagdy, Reham ;
Shawki, Mona ;
Zohni, Sahar ;
Shehawy, Islam .
EGYPTIAN JOURNAL OF PEDIATRIC ALLERGY AND IMMUNOLOGY, 2018, 16 (01) :7-14